GTX85007
NDUFB9 antibody
Eine Lieferung in diese Region ist nicht möglich.
- SKU:
- GTX85007
- Zusätzliche Namen:
- NADH:ubiquinone oxidoreductase subunit B9 , B22 , CI-B22 , LYRM3 , MC1DN24 , UQOR22
- Anwendung:
- ELISA, WB, IHC-P
- Konzentration:
- 1 mg/ml
- Physischer Zustand:
- Liquid
- Spezies-Reaktivität:
- Human
- Aufreinigung:
- Affinity Purified
- Lagerbedingungen:
- -20[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., 2-8[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., -20[o]C/-70[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted.
- Hersteller:
- Genetex
- Host:
- Rabbit
- Reaktivitäten:
- Human, Mouse, Rat
- Buffer:
- PBS, 0.02% Sodium azide.
- Immunogen:
- LYRM3 antibody was raised against a 17 amino acid synthetic peptide near the carboxy terminus of human LYRM3.The immunogen is located within the last 50 amino acids of LYRM3.
- Uniprot:
- Q9Y6M9
- Synonyme:
- B22;CI-B22;complex I B22 subunit;Complex I-B22;LYR motif-containing protein 3;LYRM3;MC1DN24;NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9;NADH-ubiquinone oxidoreductase B22 subunit;UQOR22
- Weitere Details:
- NDUFB9, also known as NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 (NDUFB9), is a ubiquitously expressed LYR-motif containing protein. It has been suggested to be a candidate gene for the branchio-oto-renal (BOR) syndrome, which is characterized by branchial and renal abnormalities and heredity deafness disorders. Other than its LYR-motif, LYRM3 appears to have no functional or structural relationship to either LYRM1 or LYRM2.
- Versandbedingungen:
- Blue Ice